TRT Cost Monthly: What You Actually Pay in 2025

How Much Does TRT Cost Per Month?

The monthly cost of testosterone replacement therapy is not a single number. It shifts depending on the formulation your physician prescribes, the pharmacy you use, whether your insurer covers the medication, and what monitoring costs get bundled in. Generic testosterone cypionate injections cost as little as $30 per month at GoodRx prices. Brand-name transdermal gels can top $500 without insurance.

Injectable Testosterone: The Lowest-Cost Option

Testosterone cypionate 200 mg/mL (10 mL vial) lists for roughly $30, $60 per month at major pharmacy chains when purchased with a discount card. GoodRx data confirms retail prices for cypionate fluctuate by zip code but rarely exceed $80 for a month's supply at that concentration. Testosterone enanthate is similarly priced. Both are Schedule III controlled substances requiring a written or electronic prescription from a licensed provider. [1]

Injections require syringes and needles, adding $5, $15 per month. Patients who self-inject intramuscularly at home keep total supply costs under $100. Those who visit a clinic for injection administration pay an additional office or nursing fee, typically $25, $75 per visit.

Topical Gels and Patches

AndroGel (testosterone 1.62%) and Testim carry list prices of $400, $600 per month without insurance. Generic testosterone gel 1% is available for $80, $150 per month via discount pharmacies. The FDA approved AndroGel 1% in 2000 and AndroGel 1.62% in 2011; both labels carry a Black Box Warning about secondary exposure risk in children and women. [2]

Testosterone patches (Androderm) run $200, $400 per month at retail. Skin irritation affects roughly 37% of patch users in clinical trials, which sometimes prompts a switch to another formulation and associated cost changes. [3]

Nasal Gel, Buccal Tablets, and Pellets

Natesto (testosterone nasal gel) and Striant (buccal testosterone) are brand-only and typically cost $300, $500 per month without insurance. Subcutaneous testosterone pellets (Testopel) are placed in a brief office procedure every 3 to 6 months. Pellet insertion costs $300, $700 per procedure, putting monthly pellet costs at $50, $230 depending on frequency, before factoring in the procedure fee itself.

What Does Insurance Cover for TRT?

Most commercial health insurance plans cover FDA-approved testosterone formulations for diagnosed hypogonadism, but coverage is rarely automatic. Insurers treat TRT as a specialty medication or a controlled substance requiring documentation of medical necessity.

The Diagnostic Threshold Requirement

The American Urological Association 2018 guideline states that a diagnosis of hypogonadism requires at least two morning serum total testosterone measurements below 300 ng/dL, accompanied by signs or symptoms of deficiency. [4] Insurers align their coverage criteria with this threshold. A single borderline result is rarely sufficient for approval.

The Endocrine Society Clinical Practice Guideline (2018) specifies: "We recommend making a diagnosis of androgen deficiency only in men with consistent symptoms and signs and unequivocally low serum testosterone levels." [5] Most plans require the prescribing physician to submit these lab values with the prior authorization request.

Copays and Cost-Sharing With Insurance

When a plan does cover testosterone cypionate, the generic tier copay is typically $10, $50 per month. Brand-name gels land on Tier 3 or Tier 4 formularies, where cost-sharing may be $75, $200 per fill even with coverage. Specialty tiers on some employer plans carry 20 to 30% coinsurance with no cap on absolute dollars, which can make brand gels expensive even after approval. [6]

What Insurers Commonly Exclude

Many plans exclude testosterone therapy for age-related decline (sometimes labeled "andropause" or "late-onset hypogonadism") if lab values fall within the low-normal range. Compounded testosterone from 503A pharmacies is routinely excluded because FDA has not approved those specific products. The FDA's guidance on compounded drug products notes that compounded drugs may not meet the same safety and efficacy standards as approved products. [7]

Medicare TRT Coverage: What Part D Plans Pay

Medicare covers testosterone replacement therapy under Part D (prescription drug benefit) when the drug is prescribed for an FDA-approved indication. Generic testosterone cypionate and enanthate appear on most Part D formularies at Tier 1 or Tier 2.

Part D Formulary Tiers

A 2024 analysis of CMS formulary files found that nearly all standalone Part D plans listed at least one injectable testosterone on their formulary. Centers for Medicare and Medicaid Services publishes plan formulary data annually. [8] At Tier 1, beneficiary cost-sharing after the deductible is typically $0, $10 per fill. At Tier 2, it rises to $15, $45. Brand-name gels often land on Tier 3 or higher, with cost-sharing of $40, $100 or more per month. [9]

The 2025 Medicare Part D Cap

The Inflation Reduction Act introduced a $2,000 annual out-of-pocket cap on Part D drugs starting January 1, 2025. CMS confirmed this change applies to all Part D enrollees. [10] For most TRT patients on generic injectables, this cap is unlikely to be reached. Patients using expensive brand-name testosterone gels who also take other high-cost medications may benefit meaningfully from this limit.

Medicare Advantage Considerations

Medicare Advantage (Part C) plans incorporate Part D drug benefits and may have narrower formularies or additional utilization management requirements. Prior authorization for testosterone is more common in Medicare Advantage plans than in standalone Part D. Beneficiaries should verify formulary placement each fall during Open Enrollment.

How TRT Prior Authorization Works

Prior authorization (PA) is the process by which an insurer reviews a prescription before agreeing to pay for it. For TRT, PA is common across both commercial and Medicare plans, particularly for brand-name formulations or when the prescribing physician works outside a traditional office setting.

Documents Typically Required

A complete PA submission for TRT generally includes: two serum total testosterone results below 300 ng/dL collected on separate mornings, a list of symptoms consistent with hypogonadism (per ICD-10 code E29.1 for primary hypogonadism or E23.0 for hypopituitarism), documentation that the patient is not a candidate for or has not responded to generic injectable testosterone (if requesting a brand-name gel), and a letter of medical necessity from the prescribing physician. [11]

Approval Timelines and Denial Rates

Standard PA decisions are required within 3 business days under most state regulations; urgent requests within 24 to 72 hours. The CMS Medicare managed care manual outlines these timeframes for Medicare Advantage plans. [12] Denial rates for TRT PA are not tracked publicly at a national level, but endocrinology practices report that initial denials are common when labs or symptom documentation are incomplete. Most approvals occur on appeal or resubmission with added clinical notes.

Step Therapy Requirements

Some plans require "step therapy," meaning the patient must try and fail generic injectable testosterone before the plan covers a transdermal formulation. Step therapy policies for testosterone are legal under federal rules but must include an exception process for patients with documented clinical reasons to skip the first-line agent. [13]

Online TRT Clinic Pricing

Telehealth testosterone clinics have grown substantially since 2019. They typically offer a flat monthly or quarterly fee that bundles the physician consultation, prescription, and sometimes lab work. Pricing varies by what is included.

All-Inclusive Subscription Models

Some online clinics charge $99, $199 per month and include the physician oversight, prescription, syringes, and shipping of testosterone cypionate. These models work well for self-pay patients who want price predictability. Lab work may or may not be included; read the fine print. A 2022 study in the Journal of Urology examined direct-to-consumer testosterone prescribing and found wide variation in diagnostic rigor among online providers, with some initiating treatment without confirming two separate low testosterone measurements. [14]

Fee-for-Service Online Clinics

Other telehealth platforms charge separately: an initial consultation fee of $75, $150, monthly membership of $20, $50, and then the cost of medication at pharmacy retail. For patients using insurance, this structure lets them submit medication costs to their plan while paying the clinic fee out-of-pocket.

What Online Clinics Cannot Do

No telehealth provider can prescribe controlled substances in a state where they are not licensed. Testosterone is Schedule III federally. The DEA requires a valid patient-provider relationship, which for Schedule III drugs currently includes a telehealth visit without mandatory in-person contact under pandemic-era flexibilities that have been extended through 2025. The DEA's telemedicine rules for Schedule III substances remain subject to revision. [15]

Lab Costs and Monitoring: The Hidden Line Items

Testosterone therapy requires ongoing blood work. Skipping labs is not medically appropriate and in practice is required for continued prescribing. These costs often catch patients off-guard.

Baseline and Follow-Up Testing

A baseline panel before starting TRT typically includes: serum total testosterone (two separate morning draws), LH, FSH, prolactin, CBC, comprehensive metabolic panel, PSA (for men over 40), and hematocrit. This panel costs $150, $400 at a reference lab without insurance. [16]

Follow-up testing at 3 months, then every 6 to 12 months, focuses on total testosterone, hematocrit, and PSA. The Endocrine Society recommends checking hematocrit at 3 and 6 months, then annually, given that testosterone raises red blood cell mass. [5] Hematocrit exceeding 54% is an indication to reduce dose or hold therapy. Repeat labs cost $75, $200 per visit at standard reference labs. Quest Diagnostics and LabCorp both offer self-pay pricing for hormone panels.

PSA Monitoring

The AUA recommends PSA screening discussion before initiating TRT in men over 40. The AUA's 2023 early detection guideline addresses this decision in the context of shared decision-making. [17] An elevated PSA at baseline or a rapid rise after starting TRT (greater than 1.4 ng/mL over any 12-month period) warrants urology referral. PSA testing costs $20, $60 at self-pay labs.

HSA, FSA, and Other Ways to Reduce Out-of-Pocket Cost

Testosterone prescriptions are qualified medical expenses under IRS Publication 502, making them eligible for Health Savings Account (HSA) and Flexible Spending Account (FSA) dollars. The IRS defines qualified medical expenses in Publication 502. [18] Paying for TRT with pre-tax HSA funds effectively reduces the real cost by your marginal tax rate, 22 to 37% for most working adults.

GoodRx and Pharmacy Discount Cards

For patients without insurance coverage, GoodRx and similar discount programs can reduce testosterone cypionate costs to $25, $50 per month at major retail chains. These cards cannot be combined with Medicare Part D; using one at the pharmacy means the claim does not count toward your Part D deductible or out-of-pocket maximum. [19]

Manufacturer Coupons

AbbVie offers savings cards for AndroGel that reduce copays for commercially insured patients, sometimes to $0 for the first fill. These programs are not available to Medicare or Medicaid beneficiaries due to federal anti-kickback rules. The OIG has addressed manufacturer copay assistance programs in multiple advisory opinions. [20]

Cost Comparison Table: TRT Formulations at a Glance

| Formulation | Brand Example | Generic Available | Monthly Cost (Self-Pay) | Insurance Tier Typical | |---|---|---|---|---| | Testosterone cypionate injection | Depo-Testosterone | Yes | $30, $60 | Tier 1 to 2 | | Testosterone enanthate injection | Delatestryl | Yes | $35, $70 | Tier 1 to 2 | | Testosterone gel 1% | AndroGel | Yes | $80, $150 | Tier 2 to 3 | | Testosterone gel 1.62% | AndroGel 1.62% | Limited | $400, $600 | Tier 3 to 4 | | Testosterone patch | Androderm | No | $200, $400 | Tier 3 | | Nasal testosterone gel | Natesto | No | $300, $500 | Tier 4 / PA required | | Buccal testosterone | Striant | No | $300, $500 | Tier 4 / PA required | | Testosterone pellets | Testopel | No | $50, $230 (procedure cost separate) | Often excluded |

Verifying Your Own Insurance Coverage: A Step-by-Step Approach

Checking your benefits before your first prescription saves time and avoids surprise bills.

Step 1: Get Your Plan's Formulary

Call the member services number on your insurance card or log into your plan's website. Ask specifically: "Is testosterone cypionate on formulary, and what tier?" Then ask the same question for whichever brand-name product your physician prefers.

Step 2: Ask About Prior Authorization Requirements

The formulary lookup will indicate whether PA is required. If so, ask for the clinical coverage criteria document. These are sometimes called "coverage policies" or "utilization management criteria" and list exactly which labs and diagnoses the plan requires. [21]

Step 3: Request a Cost Estimate

Ask the pharmacist to run a test claim before you leave with the prescription. This gives you the exact copay based on your current deductible status. Costs change after your deductible is met, so the number may differ at different points in the year.

Step 4: Appeal a Denial

If PA is denied, your physician can submit a peer-to-peer review request, meaning the prescribing doctor speaks directly with the plan's medical reviewer. CMS requires Medicare Advantage plans to offer peer-to-peer review within 72 hours of a denial. [22] Commercial plans have similar obligations under state insurance codes. The success rate for peer-to-peer appeals is substantially higher than for written appeals alone when the clinical documentation is complete.